This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The results show promise, as vision typically improves the most during the first 4 weeks, but with lamivudine, vision continued to improve in the following 4 weeks.
On May 24, the World Health Assembly, the governing body of the WHO, ratified landmark legislation that, if implemented fully, will change the future for people living with rare diseases. It calls for concrete action plans that will have far-reaching impacts across health care systems in diverse nations around the globe. It’s a historic moment in decades-long efforts to appropriately address the needs of the approximately 400 million people who suffer from rare diseases.
The FDA grants fast track designation to TEV-53408, a promising treatment for celiac disease designed to address gluten intolerance and improve patient outcomes.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Sander Kersten, PhD, discusses the distinct roles of ANGPTL3 and ANGPTL4 in lipid metabolism, their interactions with key enzymes, the therapeutic potential of targeting these pathways in lipid-lowering strategies, and important considerations for pharmacists counseling patients on emerging ANGPTL-targeted therapies.
Sophie Lebakken: Finding a home in MLS wils1838 Fri, 05/30/2025 - 10:25 Author: Erin Wilson Sophie Lebakken took a journey through three different majors and three different colleges at the University of Minnesota to find the right place for her gifts, which turned out to be the Medical Laboratory Sciences (MLS) program. First, she tried biomedical engineering, but only enjoyed the biomedical aspect.
Ochre Bio has appointed Elaine Sullivan as senior independent non-executive director. She joins the Oxford-based RNA therapeutics company with a wealth of experience in global pharma R&D and strategic leadership. Sullivan previously served as vice president of global external R&D at Eli Lilly, where she managed a $100m portfolio, and as vice president at AstraZeneca, […] The post Ochre Bio appoints Elaine Sullivan as senior independent non-executive director appeared first on Pharm
59
59
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Ochre Bio has appointed Elaine Sullivan as senior independent non-executive director. She joins the Oxford-based RNA therapeutics company with a wealth of experience in global pharma R&D and strategic leadership. Sullivan previously served as vice president of global external R&D at Eli Lilly, where she managed a $100m portfolio, and as vice president at AstraZeneca, […] The post Ochre Bio appoints Elaine Sullivan as senior independent non-executive director appeared first on Pharm
Joelle Simpson: Working in the spotlight and behind the scenes eomizowh Fri, 05/30/2025 - 11:15 Author: Erin Wilson Miss South Dakota is pursuing her Bachelors degree in Medical Laboratory Sciences (MLS), but she must defer a year to tend to the duties of her crown and to prepare for the 2025 Miss America pageant in January. This is Joelle Simpsons first year competing in pageants, though shes used to being in the spotlight; shes South Dakotas first quadruple gold medalist figure skater and a pr
Explore how Pierre Fabre and experts like Thodore Leondaridis, Dr Francesco Hofmann, and Nuria Perez Cullell are revolutionising the lung cancer space through innovation, real-world data, and precision medicine. Gain insights into their groundbreaking work.
PQA members and health care quality professionals gathered in Tampa, Fla., May 19-21, for the 2025 PQA Annual Meeting. Over those three days, health care executives and quality professionals from pharmacies, health plans, health care providers, pharmacy benefit managers, life sciences companies, technology vendors, research institutions, academia and more addressed top issues and emerging trends in medication quality, measure development and implementation, care transformation and technology.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical microbiology conferences give attendees the opportunity to learn, grow, and meet interesting colleagues. See the benefits of Pharmig events now. The post How Going to a Conference Can Strengthen Your Microbiological Knowledge appeared first on Pharmig.
Wes Flint: forging a new path in medical laboratory science eomizowh Fri, 05/30/2025 - 11:18 Author: Erin Wilson Before finding their way to the College of Pharmacy, student Wesley Flint sought a middle ground between a love for chemistry and biology and an aspiration to work in the medical field. He first heard of medical laboratory sciences during orientation at a different university described as test tubes, petri dishes and turning peoples fluids into numbers for treatment.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Maddie Everson: Improving everyday lives eomizowh Fri, 05/30/2025 - 11:22 Maddie Everson with her client. Author: Erin Wilson Ph Before switching to a pre-occupational therapy track, student Maddie Everson was pursuing physical therapy for her undergraduate degree in exercise science at the University of Wisconsin LaCrosse. I just like the idea of helping people in their everyday lives and making their days easier, rather than rehabilitation from an injury, Everson said.
Hailey Molloy: a creative and historical approach to OT eomizowh Fri, 05/30/2025 - 11:22 Author: Erin Wilson From a young age, occupational therapy (OT) student Hailey Molloy knew she wanted to help people, though she wasnt yet sure how. Her first exposure to OT was young, when her teenage cousin was involved in a severe car accident, resulting in a traumatic brain injury that was expected to end her life.
Shore Medical Center enhances patient safety with a pharmacy-driven intravenous to oral opioid conversion protocol, minimizing risks and improving pain management.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
OT student seeks to support families waitlisted for diagnostic evaluation eomizowh Fri, 05/30/2025 - 11:40 For her doctorate capstone project, occupational therapy student Bruktawit Zewdie is interviewing parents of children on the autism spectrum who have been waitlisted for evaluation or intervention. Shes working with the TeleOutreach Center at the Masonic Institute for the Developing Brain, which she was introduced to during her time as a MNLEND fellow.
Amitriptyline is a tricyclic antidepressant commonly prescribed to treat depressive disorders , certain types of chronic pain (like fibromyalgia ), and occasionally sleep issues. It works by increasing levels of specific neurotransmitters in the brain, particularly norepinephrine and serotonin. Its typically taken daily, on a long-term basis. If you’ve just been prescribed amitriptyline, you might be wondering whether it’s ever okay to take part in happy hour while taking this medica
Katherine H. Saunders, MD, DABOM, explores the role of pharmacists in supporting long-term weight management with GLP-1 therapies, including strategies for counseling on lifestyle interventions, managing adverse effects, and ensuring patients receive individualized, evidence-based care.
A panelist discusses how the PALOMA-3 study demonstrated that subcutaneous amivantamab is noninferior to intravenous (IV) administration with significantly lower infusion-related reaction (IRR) rates (13% vs 66%), shorter administration time (5 minutes vs 5 hours), higher patient-reported convenience (85% vs 35%), and improved clinical outcomes, making it potentially preferable for most eligible patients once FDA approved.
Panelists discuss how recent FDA approvals and evolving evidence for second-line treatments, including ruxolitinib, ibrutinib, and belumosudil, are reshaping chronic graft-vs-host disease (cGVHD) management by offering tailored, evidence-based options for steroid-refractory patients.
Panelists discuss how factors such as patient preferences, disease severity, organ-specific involvement, and adverse effect profiles influence the selection of second-line therapies for steroid-refractory chronic graft-vs-host disease (cGVHD) in the context of multiple FDA-approved agents.
A panelist discusses how maintaining efficacy while preserving quality of life requires personalized approaches including dose adjustments or agent rotation based on specific toxicities, and how selecting the appropriate EGFR inhibitor depends on patient comorbidities, performance status, baseline conditions (such as interstitial lung disease or cardiac issues), and patient preferences.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content